Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-CAPP Study II low-dose aspirin for prevention of colorectal tumor recurrence
jRCTs051180161Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of aspirin in colon adenoma and Colorectal carcinoma in situ, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Incidence of newly diagnosed colorectal index lesion. Started Sep 2015; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
colon adenomaColorectal carcinoma in situ
Beyond the preview
Go deeper on jRCTs051180161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180161.